Public list: Pharma Startups (4734) Cancer Therapeutics (1145)
PowderMed is developing vaccines for the treatment of chronic infectious diseases and cancer. The company uses DNA coated gold particles delivered by a needle-free injection device to stimulate a powerful and specific T cell immune response. PowderMe...Show all
Company (Acquired)
Phone:
Oxford,
United Kingdom
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|